Latest Regulatory News

Orezone Gold Corporation has announced a transformative acquisition of the Casa Berardi gold mine in Quebec, marking its entry into a Tier 1 mining jurisdiction and significantly boosting production and cash flow.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.

Mont Royal Resources has signed a non-binding Memorandum of Understanding with the Saguenay Port Authority to explore locating a hydrometallurgical facility for its Ashram Rare Earths Project in Québec, leveraging the port’s strategic logistics and industrial infrastructure.

EDU Holdings Limited anticipates FY25 financial results near the top of its guidance, driven by strong revenue and profit growth from its higher education arm, Ikon Institute.

Euro Manganese has confirmed no material changes in its operations amid recent spikes in market activity, reassuring investors and regulators alike.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.

Ragusa Minerals has significantly expanded its Purple Pansy Manganese-Gold Project in Arizona by acquiring 201 additional tenements, enhancing its strategic landholding and exploration potential in a critical minerals hotspot.

PC Gold Ltd has secured approvals to re-open the historical Spring Hill underground adit, enabling cost-effective underground drilling to assess high-grade gold mineralisation and potentially expand its resource base.

QPM Energy has taken a significant step forward by signing a key agreement with Powerlink Queensland to connect its 112MW Isaac Power Station to the grid, targeting energisation by mid-2027.

Botanix Pharmaceuticals reported a robust 28% increase in net revenue for Sofdra in Q2 FY26, driven by a 24% rise in prescriptions and a growing US sales team. The company maintains a strong cash position while navigating higher operating costs.

Canadian Phosphate Limited has improved its operating cash flow and strengthened its balance sheet through a successful capital raise and asset sale, while advancing key permits and strategic partnerships for its Canadian phosphate projects.